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ABSTRACT. Retinal nerve fiber layer (RNFL) photographs from 26 pa- 
tients with Alzheimer’s disease and 23 normal, age-matched, control 
subjects were reviewed for quality and abnormalities by two observers. A 
higher proportion of Alzheimer’s patients showed RNFL abnormalities 
when compared to control subjects. There was some disagreement be- 
tween the two observers regarding quality and frequency of abnor- 
malities, reflecting suboptimal quality of the photographs obtained in pa- 
tients with advanced Alzheimer’s disease. Although these findings add to 
the clinical and histopathological evidence that ganglion cell degener- 
ation occurs in Alzheimer’s disease, the difficulty in obtaining and evalu- 
ating retinal nerve fiber layer photographs, especially in advanced cases, 
may limit the clinical usefulness of retinal nerve fiber layer analysis in 
such patients. 
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here has been continued interest T and some controversy regarding 
the visual effects of Alzheimer’s dis- 
ease. Although it is clear that many of 
the visual problems associated with 
Alzheimer’s disease are due to cortical 
dysfunction (Schlotterer et al. 1983; 
Cogan 1985, Kiyosawa et al. 1989; 
Mendez et al. 1990; Cronin-Golomb et 
a]. 1991; Levine et al. 1993; Hutton et 
al. 1993) and, although eye movement 
abnormalities may play a role (Feldon 
& Langston 1977; Fletcher & Sharpe 
1988), there is evidence that optic 
nerve dysfunction, due to retinal gan- 
glion cell loss, also may occur in Alz- 
heimer’s disease (Hinton et al. 1986; 
Sadun et al. 1987; Sadun & Bassi 
1990). Some of the evidence for optic 
neuropathy is based on autopsy studies 
(Hinton et al. 1986; Sadun & Bassi 
1990), but clinical studies of optic 
nerve function have been based on 
subjective responses to tests of optic 
nerve function, such as visual field and 
color vision testing, as well as visual 
evoked potential recording and obser- 
vation of optic disc color and contour 
(Cogan 1985; Cronin-Golomb et al. 
1991; Sadun et al. 1987; Nissen et al. 
1985; Rizzo et al. 1992; Katz et al. 
1989). Clinical evaluation of the reti- 
nal nerve fiber layer has been shown to 
be an excellent way to detect and 
measure the effects of a variety of dis- 
eases on the optic nerve (Quigley et a]. 
1982; Peli et al. 1987). So far, only one 
study, which was primarily directed to- 
ward analysis of the appearance of the 
optic nerve head, has included evalu- 
ation of the clinical appearance of the 
retinal nerve fiber layer (Tsai et al. 
1991). Photographs of variable quality, 
from 24 patients with Alzheimer’s dis- 
ease reviewed by one reader, showed a 
significant number of abnormalities, 
indicating the need for further study in 
this area. We evaluated the retinal 
nerve fiber layer in a group of Alz- 
heimer’s patients in various stages of 
Alzheimer’s disease, including later 
stages. To control for quality of photo- 
graphs, two observers were asked to 
review photographs in a masked 
fashion allowing for comparison of 
intra- and inter-observer variability. 
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Photographs from 19 normal subjects 
were collected. These individuals had 
no evidence of glaucoma, nutritional, 
or other optic nerve disease. Clinically 
normal eyes from two patients with 
contralateral anterior ischemic optic 
neuropathy, and the normal eyes from 
two patients with optic neuropathy 
from compression of the contralateral 
optic nerve (aneurysm in one and optic 
nerve sheath meningioma in the other) 
were also used. All normal subject eyes 
had normal Goldmann or automated 
visual fields (Octopus 2000, Inter- 
zeag), color vision, acuity, intraocular 
prcssures and clinical examination, ex- 
cept for lens changes associated with 
age. Ages in the control group range 
from 52-93 years with a mean of 71 
years. 
Alzheimer’s patients 
Forty-seven patients were evaluated 
for the study. All patients satisfied the 
National Institutes of Health and Alz- 
heimer’s Disease and Related Dis- 
orders Association (NINCDS/ 
ADRDA) criteria for the diagnosis of 
probable Alzheimer’s disease (Mc- 
Khann et al. 1984). All patients were, 
or continue to be, part of other studies 
of Alzheimer’s disease at either Tufts 
University (New England Medical 
Center, Boston, Massachusetts), Har- 
vard University (Brigham and 
Women’s Hospital, Boston, Massachu- 
setts), or Yale University (Jewish 
Home for the Elderly, Fairfield, Con- 
necticut). Records were thoroughly re- 
viewed to exclude patients with nutri- 
tional deficiency, focal neurologic dis- 
ease (such as stroke), and alcoholism. 
All patients had computed tomo- 
graphy or magnetic resonance imaging 
which showed no evidence of focal 
neurologic disease. All patients had 
previous eye examinations showing no 
evidence of glaucoma, senile macular 
degeneration, other optic neuropa- 
thies (such as anterior ischemic optic 
neuropathy), or retinal artery occlu- 
sions. 
Because different types of mental 
status examinations had been per- 
formed on different patients, a separ- 
ate dementia scale was created. 
Stage 1: Mild memoryAanguage, 
behavioral difficulties, able to care for 
self. 
Stage 2: Moderate memory/lan- 
guage, behavioral difficulties, but re- 
quiring constant supervision. 
Stage 3: Severe dementia, some lan- 
guage function remaining, able to fol- 
low simple commands. 
Sznge 4: Complete loss of language 
and ability to ambulate. Unable to fol- 
low commands. 
Ages of patients with Alzheimer’s 
disease ranged from 54 to 93 years 
with a mean of 73 years. 
Ophthalmic examination 
All patients were evaluated for visual 
acuity when possible. Visual fields 
were usually performed by Goldmann 
perimetry, and by confrontation in pa- 
tients in the later stages of the disease. 
Color vision using American Optical 
Hardey Ritter Rand color plates was 
performed on cooperative individuals. 
All patients had their refractive errors 
assessed by either standard refraction 
techniques or retinoscopy. All patients 
had intraocular pressure measured 
using applanation tonometry. Slit- 
lamp examinations were performed on 
all cooperative patients to rule out sig- 
nificant cataract. Dilated funduscopic 
examination was performed on all in- 
dividuals. 
Photographic techniques 
All photographs were taken either with 
a Canon CF-60Z or a Zeiss FK 30 fun- 
dus camera. A SE-4 blue fluorescein 
excitor filter was used in patients with- 
out significant cataract, and an SE- 
540, green, interference filter was used 
for patients with mild cataract. Color 
photographs were obtained using Fu- 
gichrome slide film. All red-free, black 
and white photographs were taken 
using Panatomic X film, using 30 de- 
gree fields of four quadrants around 
the optic disc, attempting to obtain at 
least two photographs per quadrant. 
Between 10-30 photographs per eye 
were taken on all patients. 
Photograph selection 
Of the 47 patients entered in the study, 
34 patients were cooperative enough 
for photography. However, prelimi- 
nary analysis of the photographs 
showed that those from eight patients 
with Alzheimer’s disease were deter- 
mined to be too poor or too few for 
analysis. This left photographs from 26 
Alzheimer’s patients and 23 control 
subjects for further analysis for both 
quality and abnormalities. 
Photograph analysis 
In order to standardize material for 
each patient, and because of the vari- 
able number of photographs taken for 
each patient, it was decided that a 
masked analysis should include two 
observers using the best quality photo- 
graphs available. A preliminary ana- 
lysis for retinal nerve fiber layer defects 
showed that, of 15 patients who were 
found to have abnormalities, 14 had 
abnormalities in both eyes, giving an 
inter-eye correlation of 0.99. It was de- 
cided that the best photographs of one 
eye from each patient and each normal 
subject would be shown to one obser- 
ver on two occasions and to another 
observer on another occasion. Follow- 
ing this, all slides from Alzheimer’s pa- 
tients and all control subjects were 
made available to one observer for un- 
masked analysis. 
During the first reading, by observer 
1 (TRH), the best photograph from 
each quadrant from the slides selected 
from 26 Alzheimer’s patients ran- 
domly mixed with slides from 23 con- 
trol subjects were shown in a masked 
fashion. A second reading was per- 
formed by observer 1 (TRH 2), this 
time using photographs from the 
superotemporal quadrant from 26 pa- 
tients with Alzheimer’s disease and 19 
control patients. Observer 2 (EP) was 
shown superotemporal photographs 
from the same 26 Alzheimer’s patients 
and 19 normal subjects. An additional 
reading of all photographs from both 
eyes of 26 Alzheimer’s patients and 23 
normal subjects were reviewed in an 
unmasked fashion by observer 1. 
The observers identified the photo- 
graphs as normal (Fig. I ) ,  abnormal, or 
unreadable. Abnormal photographs 
were further qualified as having either 
diffuse nerve layer drop-out, slit de- 
fects, or wedge defects. Diffuse drop- 
out was determined by loss of stria- 
tions on the surface of the retina com- 
bined with prominence of small blood 
vessels running perpendicular to the 
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Fig. 1. Inferior temporal quadrant of a left fundus showing normal 
retinal nerve fiber layer striations. 
Fig. 2. Superior temporal quadrant of a left fundus showing diffuse 
loss of the retinal nerve fiber layer with exposure of blood vessels. 
nerve fiber layer throughout the photo- 
graph (Fig. 2). Slit defects were identi- 
fied as dark lines running parallel to 
normal nerve fiber striations extending 
from the optic disc for a distance of at 
least 2 optic disc diameters (Fig. 3). 
Wedge defects were determined as slit 
defects greater than the width of a large 
vein (200 microns). 
Statistical analysis 
Odds ratios and 95% confidence in- 
tervals for RNFL abnormalities deter- 
mined for each observation were cal- 
culated from logistic regression model 
(Homer & Lemeshow 1989), of the 
presence or absence of RNFL abnor- 
malities relative to age, and stage of 
Alzheimer’s disease. Inter- and intra- 
observer comparisons were made by 
determining kappa statistics and per- 
cent concordance. This was done with 
regard to differences which occurred 
in determinations of quality of photo- 
graphs as well as abnormalities de- 
tected by the two observers (inter-ob- 
server agreement), as well as abnor- 
malities detected by the same observer 
on different occasions (intra-observer 
agreement). For most purposes, kappa 
values greater than 0.75 may be con- 
sidered to represent excellent agree- 
ment beyond chance, and values below 
0.40 may be considered to represent 
poor agreement (Fleiss 1981). 
Results 
Staging of Alzheimer’s disease 
Of those individuals determined to 
have readable photographs by obser- 
ver 1, after the first observation, the se- 
verity of Alzheimer’s disease was as 
follows: 10 patients were placed in 
stage 1, 10 patients in stage 2, 3 pa- 
tients in stage 3, and 2 patients in stage 
4. Of these 25 patients, 12 had mini 
Fig. 3. 
Superior temporal 
quadrant of a left 
fundus showing 
several slit defects in 
the retinal nerve fiber 
layer. 
mental status examinations. Although 
there was some overlap in test scores, 
the mean test scores among the pa- 
tients were as follows: in stage l ,  21.0, 
in stage 2, 15.8, in stage 3, 5.5, and in 
stage 4,0. 
Neuro-ophthalmic findings 
Neuro-ophthalmic symptoms de- 
scribed by some patients, included dif- 
ficulty reading in 2 individuals, visual 
spatial disorientation in 2 patients, and 
visual hallucinations in 1 subject. 
Clinical evaluation showed optic disc 
pallor in 1 patient. Visual field defects 
using Goldmann perimetry are found 
in none of 13 patients tested. Color vi- 
sion defects were found in 3 of 7 pa- 
tients tested, and color naming diffi- 
culty was noted in 1 of the 7 patients 
tested. An abnormal pattern evoked 
potential was obtained in 1 of 9 pa- 
tients tested, and one individual had a 
normal pattern evoked potential but an 
abnormal flash evoked potential. Ocu- 
lar motor findings included abnormal 
saccades in 4 of 26 patients, delayed 
re-fixation in 8 of 26 patients and pur- 
suit deficits in 18 of 26 patients. 
Retinal nerve fiber layer abnormalities 
Findings by observer 1 (both masked 
readings), observer 2, (single masked 
reading) and observer 1 (unmasked 
reading) are shown in Table 1. Odds ra- 
tios for unmasked observations range 
from 4.1 to 11.2. Observer 2 did not see 
a significant difference between Alz- 
heimer’s patients and normal subjects. 
However, review of all available photo- 
graphs from both Alzheimer’s patients 
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Table 1. (NI: normal. Abn: abnormal. Rej: reject). 
Control subjects Alzheimer’s patients Odds 95% confidence 
~1 Abn ~~j ~1 Abn ~~j ratio interval 
TRH- 1 18 3 2 12 13 1 6.50 1.3 - 36.7 
TRH-2 14 1 4 10 8 8  1 1.20 1.06 - 279.0 
EP I I  3 5 8 9 9  4.13 0.67 - 28.1 
TRHunmasked I Y  2 2 13 1 1  1 8.04 1.36 - 3.2 
and controls including both eyes (un- 
masked) showed an odds ratio of 8.0 
(p<0.01, 95% confidence interval 1.3- 
63.2). 
Types of nerve fiber layer abnor- 
malities based on observations by the 
first observer of 13 patients with ab- 
normalities includes diffuse nerve 
fiber layer drop-out (10 patients), slit 
defects ( 1  patient), and diffuse nerve 
fiber layer drop-out plus slits (2 pa- 
tients). 
Retinal nerve fiber layer abnormalities 
and stage of disease 
Using a logistic regression analysis of 
presence or absence of RNFL abnor- 
malities on stage of the disease and age, 
a trend towards increasing abnor- 
malities with progressive stages of the 
disease occurred. This trend was not 
statistically significant (Fig. 4 - histo- 
gram). 
Inter-observer and intra-observer 
comparisons 
Comparisons were done between dif- 
ferent observations for quality of 
photographs. Comparing readings 
from observer 1, the percent concord- 
ance of intra-observer agreement was 
73.5”/0 for Alzheimer’s patients and 
control subjects combined (kappa = 
0.17 for Alzheimer’s patients, 0.31 for 
controls, and 0.23 for both). Inter-ob- 
server agreement between the second 
reading by observer 1 and the reading 
by observer 2, was 68.8% for Alz- 
heimer’s patients and control subjects 
combined (kappa = 0.14 for Alz- 
heimer’s patients, 0.25 for controls and 
0.19 for both). 
The intra-observer concordance for 
assessment of abnormalities, observer 
1, first analysis vs second analysis was 
96.9% (kappa = 0.93). Percent con- 
cordance for inter-observer analysis 
for abnormalities (observer 1 (first 
reading) vs. observer 2) was 76.7% 
(kappa = 0.58). 
Discussion 
Several studies of visual function in pa- 
tients with Alzheimer’s disease indi- 
cate that there is a problem with central 
processing of visual information in af- 
fected individuals (Schlotterer et al. 
1983; Cogan 1985; Kiyosawa et al. 
1989; Mendez et al. 1990; Cronin-Go- 
lopmb et al. 1991; Levine et al. 1993; 
Hutton et al. 1993). However, there has 
been increasing evidence of involve- 
ment of the anterior visual pathways, 
especially since Hinton et al. found re- 
duced numbers of ganglion cells and 
axons in an autopsy study of patients 
with Alzheimer’s disease (Hinton et al. 
1986). More recently, it has been sug- 
,I ,111I- ~- 
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Fig. 4. Retinal nerve fiber layer findings: Alzheimer’s vs control subjects (TRH-I). 
gested that large, M-cell axons may be 
the first to degenerate in Alzheimer’s 
disease (Sadun & Bassi 1990). Clinical 
evidence for optic neuropathy in Alz- 
heimer’s disease has been provided by 
several studies (Sadun & Bassi 1990; 
Katz et al. 1989), although others have 
found no evidence of significant optic 
nerve changes in Alzheimer’s disease 
(Cronin-Golomb et al. 1991; Rizzo et 
al. 1992). Only one study has included 
specific evaluation of the retinal nerve 
fiber layer (RNFL) in patients with 
Alzheimer’s disease (Tsai et al. 1991). 
The authors of this study found a 
higher proportion of RNFL abnor- 
malities among 26 patients with Alz- 
heimer’s disease as compared to 32 
control patients when examined with 
red free photography. Although the 
pallor-area to disc-area ratio was not 
significantly different between patients 
with Alzheimer’s disease and controls, 
the Alzheimer’s patients with higher 
pallor-area to disc-area as well as those 
with increased cup-disc ratios and in- 
creased cup volume and decreased 
disc-rim areas had higher Alzheimer’s 
disease assessment scale scores. In the 
same study, of 26 patients photo- 
graphed, 22 had red free, RNFL 
photographs of high enough quality for 
evaluation. Of these, 5 were found to 
have normal RNFL. The numbers of 
photographs per patient and the spe- 
cific problems regarding quality of 
photographs were not noted (Schlot- 
terer 1983). 
In the present study, we also had 
problems with the number and quality 
of photographs. It was recognized 
early in the study that this would be a 
problem primarily because patients 
with Alzheimer’s disease are less co- 
operative for photography, and, be- 
cause they are more likely to have age- 
related lens opacities. Therefore, we 
decided to incorporate into the study a 
mechanism for evaluation of varia- 
bility in photographic evaluation in 
order to determine if our findings were 
reliable. Before reviewing all photo- 
graphs available, selected photographs 
(the best single photograph available 
for each patient) were shown to one 
observer on two occasions to calculate 
inter-observer variability, and to a sec- 
ond observer to calculate intra-obser- 
ver variability. Furthermore, compari- 
sons of photographic quality as well as 
- 274 
ACTA OPHTHALMOLOGICA SCANDINAVICA 1996 - 
incidence of RNFL abnormalities 
were made. The concordance for intra- 
observer agreement of 73.5°/0 and the 
inter-observer agreement of 68.8% for 
quality may reflect the overall, less than 
optimal, quality of the photographs. 
The intra-observer agreement for 
RNFL abnormalities of 96.9% and the 
inter-observer agreement for RNFL 
abnormalities of 76.7% may have been 
related to the greater number of photo- 
graphs rejected by observer 2. 
Whether our findings, and those of 
others will be clinically useful in the di- 
agnosis and treatment of Alzheimer’s 
disease remains to be seen. Further- 
more, our findings do not help deter- 
mine the extent to which anterior vis- 
ual pathway changes in Alzheimer’s 
disease contribute to the central ab- 
normalities of visual function found in 
these individuals. Although we could 
not demonstrate a definite increase in 
the frequency of RNFL abnormalities 
with increasing severity or duration of 
Alzheimer’s disease in our patients, 
because of the low number of individ- 
uals in the very late stages of the dis- 
ease, our findings and those of Tsai et 
al. (1991) suggest that optic nerve de- 
generation with Alzheimer’s disease is 
progressive. To the extent that abnor- 
malities of the RNFL could be associ- 
ated with earlier or later mortality, any 
study including only survivors, could 
be biased. A longitudinal study of 
RNFL findings in a cohort of early 
Alzheimer’s patients followed 
throughout their course would be 
needed to determine the relationship 
between RNFL abnormalities and 
Alzheimer’s disease and to determine 
if detection and monitoring of RNFL 
changes will be of use in diagnosis or 
prognosis as well as determining re- 
sponse to treatment of patients with 
Alzheimer’s disease. 
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